<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Isolated impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG) and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) are two risk categories for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This study compared both categories with respect to the degree of insulin secretion abnormalities and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: This is a crossover comparison of a population at high risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The subjects were recruited from the Risk Factor in <z:hpo ids='HP_0000833'>Impaired Glucose Tolerance</z:hpo> for <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> and <z:mp ids='MP_0002055'>Diabetes</z:mp> (RIAD) study </plain></SENT>
<SENT sid="4" pm="."><plain>They underwent a 75-g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test, with measurement of specific insulin, C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, proinsulin, and free fatty acids at baseline and every 30 min after load for 2 h </plain></SENT>
<SENT sid="5" pm="."><plain>Factor analysis was performed to evaluate the importance of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and secretion abnormalities in both categories </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> categories of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> had a higher <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> level when adjusted for sex, age, and BMI compared to control subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="7" pm="."><plain>Subjects with isolated IFG were more insulin resistant than those with IGT </plain></SENT>
<SENT sid="8" pm="."><plain>By contrast, subjects with isolated IGT exhibited a more severe deficit in early- and late-phase insulin secretion versus IFG subjects </plain></SENT>
<SENT sid="9" pm="."><plain>As shown with factor analysis, in IFG the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> factor explained 28.4% of the variance, whereas in IGT the insulin secretion factor was dominant, explaining 31.1% of the total variance </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our cross-sectional data from the RIAD study demonstrate that isolated IFG and isolated IGT are different with respect to the degree of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and anomalies in insulin secretion, and that subjects with IGT exhibit a deficit in the early and late phases of insulin secretion </plain></SENT>
<SENT sid="11" pm="."><plain>This finding may be important for a differential approach in primary prevention of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>